In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Assessment and management of patients with myocardial infraction and shock
Session

Event : ESC Congress 2019

Topic : Acute Coronary Syndromes - Clinical

  • Session type : Moderated Posters
  • Date : 01 September 2019
  • Time : 17:45 - 18:35

5 presentations in this session

Cardiogenic shock without severe left ventricular dysfunction after st-elevation acute myocardial infarction: population characterization and impact in prognosis

Event : ESC Congress 2019

  • Session : Assessment and management of patients with myocardial infraction and shock
  • Speaker : BC Picarra (Elvas,PT)

The predictor of mortality and neurological outcome in out-of-hospital cardiac arrest patients with non-ST-segment elevation

Event : ESC Congress 2019

  • Session : Assessment and management of patients with myocardial infraction and shock
  • Speaker : J Matsuda (Saitama,JP)

CTEPH patients long term follow-up: results from a single center

Event : ESC Congress 2019

  • Session : Assessment and management of patients with myocardial infraction and shock
  • Speaker : S Mladoniczky (Gyongyos,HU)

Incidence and prognostic impact of sepsis in patients with acute myocardial infarction complicated by cardiogenic shock - Results of the CULPRIT-SHOCK study and registry

Event : ESC Congress 2019

  • Session : Assessment and management of patients with myocardial infraction and shock
  • Speaker : U Zeymer (Ludwigshafen,DE)

IABP-SHOCK II risk score validation for cardiogenic shock after myocardial infarction in a cohort treated with pharmaco-invasive therapy

Event : ESC Congress 2019

  • Session : Assessment and management of patients with myocardial infraction and shock
  • Speaker : P Moraes (Sao Paulo,BR)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are